[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information]. [electronic resource]
Producer: 20120711Description: 513-20 p. digitalISSN:- 1769-6917
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Camptothecin -- administration & dosage
- Contraindications
- Drug Monitoring -- methods
- Family
- France
- General Practice
- Glioblastoma -- drug therapy
- Humans
- Irinotecan
- Medical Oncology -- methods
- Off-Label Use
- Pamphlets
- Patient Education as Topic -- methods
- Pharmaceutical Services
- Pharmacovigilance
- Prescription Drugs -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.